Alpha Crest Capital Management LLC Emergent Bio Solutions Inc. Transaction History

Alpha Crest Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $458,192 - $816,490	22,807 Added 210.38%	33,648 $706,000
Q2 2022 Aug 11, 2022	SELL	$27.42 - $43.63 $686,788 - $1.09 Million	-25,047 Reduced 69.79%	10,841 $337,000
Q1 2022 May 12, 2022	BUY	$36.48 - $52.22 $1.31 Million - $1.87 Million	35,888 New	35,888 $1.47 Million
Q4 2021 Feb 09, 2022	SELL	$33.11 - $55.01 $151,080 - $251,010	-4,563 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$50.07 - $66.05 $29,040 - $38,309	580 Added 14.56%	4,563 $228,000
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $317,355 - $451,058	-5,606 Reduced 58.46%	3,983 $251,000
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $361,907 - $525,422	4,197 Added 77.84%	9,589 $891,000
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $250,414 - $352,579	3,163 Added 141.9%	5,392 $483,000
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $182,577 - $300,781	2,229 New	2,229 $230,000
Q2 2020 Aug 12, 2020	SELL	$54.33 - $89.52 $409,376 - $674,533	-7,535 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$49.34 - $68.76 $371,776 - $518,106	7,535 New	7,535 $436,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.